Evidence on Long COVID Diagnosis, Risk, Symptoms, and Functional Impact for Patients

Posted on | Posted on John Murphy | Leave a Comment on Evidence on Long COVID Diagnosis, Risk, Symptoms, and Functional Impact for Patients

News Release |  2024, National Academies of Sciences, Engineering, and Medicine WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine presents conclusions about Long COVID diagnosis, symptoms, and…[...]

Study Censored by The Lancet Finally Released: Confirms ‘High Likelihood of Causal Link Between COVID-19 Vaccines and Death’

Posted on | Posted on John Murphy | Leave a Comment on Study Censored by The Lancet Finally Released: Confirms ‘High Likelihood of Causal Link Between COVID-19 Vaccines and Death’

On November 17, 2024, Science, Public Health Policy and The Law journal published a peer-reviewed study titled, “A Systematic Review Of Autopsy Findings In Deaths After Covid-19 Vaccination.“ This study…[...]

NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

Posted on | Posted on John Murphy | Leave a Comment on NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

Part of the NIH RECOVER Initiative, trials will test four treatments. The National Institutes of Health (NIH) will launch clinical trials to investigate potential treatments for long-term symptoms after COVID-19…[...]

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Posted on | Posted on John Murphy | Leave a Comment on Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Authors: Bruce K. Patterson, 1 , * Edgar B. Francisco, 1 Ram Yogendra, 2 et. al., Front Immunol. 2021; 12: 746021.Published online 2022 Jan 10. doi: 10.3389/fimmu.2021. 746021PMCID: PMC8784688PMID: 35082777 Abstract The recent COVID-19 pandemic is a treatment challenge in the acute…[...]

Mesenteric Panniculitis and COVID-19: A Rare Association

Posted on | Posted on John Murphy | Leave a Comment on Mesenteric Panniculitis and COVID-19: A Rare Association

Authors: Israa A Alyousef,1Zainab A Alsaileek,1Manar A Alabdulsalam,1et. al. Cureus. 2022 Jan; 14(1): e21314. . doi: 10.7759/cureus.21314 PMCID: PMC8849467PMID: 35186573 Abstract Coronavirus disease 2019 (COVID-19) typically involves the respiratory system, but gastrointestinal involvement is common.…[...]

Role of 2-Deoxy-D-Glucose in Enhancing the Efficacy of Standard of Care for Moderate to Severe COVID-19: A Comparative Analysis of Clinical Outcomes

Posted on | Posted on John Murphy | Leave a Comment on Role of 2-Deoxy-D-Glucose in Enhancing the Efficacy of Standard of Care for Moderate to Severe COVID-19: A Comparative Analysis of Clinical Outcomes

Triven Sagar Sandepogu • Chennakesavulu Dara • Saranya Mallamgunta •, et. al. DOI: 10.7759/cureus.73993  Abstract Objective This study aimed to evaluate the role of 2-Deoxy-D-Glucose (2-DG) in moderate to severe Coronavirus Disease 2019 (COVID-19) cases. Methodology…[...]

New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria

Posted on | Posted on John Murphy | Leave a Comment on New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria

Omar Khoja, Matthew Mulvey, Sarah Astill,  et. al. doi: https://doi.org/10.1101/2024.07.10.24310234 Abstract Background: New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that…[...]